multiple myeloma
-
Antitrust litigation against Dr Reddy’s Laboratories, Celgene and Bristol-Myers Squibb in US
The complaint has asked for equitable redress and damages for alleged over payments An antitrust lawsuit was filed in the…
Read More » -
Cipla bags US FDA approval for generic version of Revlimid
The drug is indicated for several haematological malignancies in adults such as Multiple Myeloma, Myelodysplastic syndromes, Mantle cell lymphoma, Follicular…
Read More » -
MedGenome Labs launches clonoSEQ Assay in India
clonoSEQ is the first US FDA-cleared MRD test for Multiple Myeloma, Chronic Lymphoblastic Leukaemia (CLL), and B-Acute Lymphoblastic Leukaemia (B-ALL)…
Read More » -
XNK Therapeutics receives US orphan drug status
The status was received for NK cell-based immunotherapy in multiple myeloma XNK Therapeutics has received Orphan Drug Designation (ODD) from…
Read More »